C(RGDfK(N3)) hmoov yog dab tsi?
C(RGDfK(N3)) Powder(CAS: 868845-09-4) yog cyclic RGD peptide derivative uas muaj azide functional group rau bio-conjugation. Nws yog dav siv los ua kev tshawb fawb peptide hauv thaj chaw xws li kev xa tshuaj tshuaj, kev tshuaj ntsuam xyuas molecular, biomaterials, thiab kev tshawb fawb qog noj ntshav.
Cov peptide no belongs rau tsev neeg ntawm integrin- tsom ligands, tsim los tshwj xeeb khi rau v 3 integrin receptors, uas tau nthuav tawm heev hauv cov qog hlwb, cov hlab ntsha angiogenic, thiab qee cov ntaub so ntswg.
Cov ntaub ntawv tshuaj thiab cov qauv
| Khoom npe | C(RGDfK(N3)) |
| Cov lus piav qhia tag nrho | Cyclo(Arg-Gly-Asp-D-Ph-Lys(N₃))) |
| Peptide hom | Cyclic pentapeptide |
| Pab pawg ua haujlwm | Azide (–N₃) |
| Qhov tshwm sim | Dawb kom tawm -dawb lyophilized hmoov |
| Purity | Feem ntau Ntau dua lossis sib npaug li 95% (HPLC) |
| Solubility | Soluble hauv dej Soluble hauv DMSO thiab DMF |
| Cia | -20℃pom zoo |
Cov ntsiab lus tseem ceeb
Cov peptide muaj:
RGD motif (Arg-Gly-Asp)
Lub luag haujlwm rau kev lees paub integrin
D-phenylalanine
Txhim kho metabolic stability
Cyclized qaum
Txhim kho receptor affinity thiab tsis kam mus rau enzymatic degradation
Azide- hloov kho lysine
Enables nyem chemistry conjugation
Khoom Specifications rau kev tshawb fawb siv
Raws li qib siab - cov tshuaj tshawb fawb muaj txiaj ntsig, nws cov lus qhia tshwj xeeb tau lees paub tus kheej, kev coj dawb huv, thiab kev ua haujlwm.
|
Parameter |
Specification |
|
Purity (HPLC) |
Ntau dua lossis sib npaug li 95% (Standard), Ntau dua lossis sib npaug rau 98% (High-Purity) |
|
Mass Spectrometry (MS) |
ESI-MS lossis MALDI-TOF MS cov ntaub ntawv lees paub qhov tseeb molecular mass (Dawb puag: ~ 678.8 Da; Daim ntawv ntsev: + pawg ntawm counterions). |
|
Cov ntsiab lus Peptide |
Muab cov ntsiab lus peptide net (piv txwv li, "Net Nyhav: 1 mg peptide"). |
|
Amino Acid Analysis (AAA) |
Kev sib xyaw ua ke sib piv theoretical. |
|
Sterility & Endotoxin |
Tsis muaj menyuam, Endotoxin: <1.0 EU/mg (rauhauv vitrosiv). Rauhauv vivodaim ntawv thov, tshwj xeeb qis -endotoxin synthesis yog xav tau. |
|
Cia & Reconstitution |
Khaws ntawm tsawg dua lossis sib npaug rau -20 degree, qhuav.Rov ua dua nyob rau hauv siab -zoo, azide-dawb buffers (xws li, PBS, saline) los yog dej tsis muaj menyuam. Zam kom tsis txhob muaj amine- muaj cov buffers (piv txwv li, Tris) thaum lub sij hawm conjugation vim lawv tuaj yeem hnov qab. |
Kev Tshawb Fawb Kev Tshawb Fawb & Ua Ntej -Cov Ntawv Thov Kev Kho Mob
Qhov no dual{0}}functionality ua rau nws siv raws li ib tug universal platform rau tsim cov hom phiaj theranostic agents.
|
Daim ntawv thov teb |
Tshwj xeeb peb |
|
Molecular Imaging |
Tumor{0}}Targeted PET/SPECT/Fluorescent Imaging Probes |
|
Targeted Drug Delivery |
Ligand rau Active Targeting ntawm Nanocarriers. |
|
Tshuaj Biology |
Kev soj ntsuam rau Integrin Biology & Cell Surface Labeling. |
|
Theranostics |
Combined Diagnostic & Therapeutic Agents. |
Core Functional Properties: Dual -Action Molecule
Cov molecule no muaj ob qhov sib txawv, tsis tau ntxiv, txheej ntawm kev ua haujlwm:
Txheej 1: Lub Hom Phiaj Xwm Txheej (Lub "Warhead")
- Lub Hom Phiaj: v 3 Integrin Receptor. Cov receptor no tau nthuav tawm ntau dhau ntawm cov kab mob endothelial ntawm cov qog neovasculature thiab ntawm ntau cov qog nqaij hlav qog nqaij hlav (xws li, glioblastoma, melanoma, mis, mob qog nqaij hlav prostate), tab sis feem ntau tsis tuaj ntawm cov hlab ntsha, cov hlab ntsha thiab cov nqaij mos feem ntau.
- Mechanism: Cyclic RGD motif ua raws li qhov siab -affinity, tshwj xeeb ligand rau v 3. Nws txoj hlua khi tuaj yeem cuam tshuam kev sib cuam tshuam ntawm cov integrin thiab extracellular matrix proteins (xws li vitronectin thiab fibronectin), cuam tshuam pro- ciaj sia taus thiab pro{{3}angiogenic.
Txheej 2: Tshuaj Conjugation (Lub "Handle")
Reactive Group: Azide (-N₃) yog ib pawg me me, ruaj khov, thiab bioorthogonal ua haujlwm.
Conjugation Chemistry: Nws nkag siab koom nrog Click Chemistry cov tshuaj tiv thaiv, feem ntau:
- Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC): Nrog lub davhlau ya nyob twg alkynes, catalyzed los ntawm Cu(I).
- Hom -Promoted Azide-Alkyne Cycloaddition (SPAAC): Nrog strained cyclooctynes (xws li, DBCO, BCN) - qhov tseem ceeb, cov tshuaj tiv thaiv no yuav tsum tsis muaj cytotoxic tooj liab catalyst, ua rau nws zoo tagnrho rau hauv vitro thiab vivo daim ntaub ntawv.
Kev siv hluav taws xob:Qhov no tso cai rau covalent, qhov chaw - tshwj xeeb, thiab siab - ua haujlwm tau zoo ntawm txhua yam molecule uas muaj "nyem" tus khub (alkyne/cyclooctyne).
C(RGDfK(N3)) Powder(CAS: 868845-09-}4) yog ib tug high-affinity cyclic RGD peptide nrog azide functional pab pawg, ua rau nws yog ib tug haib cuab tam rau integrin-targeted imaging, xa tshuaj, thiab biomaterials tshawb fawb. Nws txoj kev ruaj ntseg, tshwj xeeb rau v 3 integrin, thiab kev sib raug zoo nrog nias chemistry ua rau nws muaj txiaj ntsig zoo hauv kev tshawb fawb biomedical thiab tshuaj niaj hnub.
Cim npe nrov: c(rgdfk(n3)) hmoov cas 868845-09-4, Tuam Tshoj c(rgdfk(n3)) hmoov cas 868845-09-4 manufacturers, lwm tus neeg, Hoobkas


